D. Western Therapeutics Institute
4576
Needs Well
3992
Daiwa Cycle
5888
Osaka Yuka Industry
4124
Liberta
4935
JP Stock MarketDetailed Quotes
5821 Hirakawa Hewtech
- 1541
- +6+0.39%
20min DelayNot Open Dec 17 15:30 JST
27.16BMarket Cap14.99P/E (Static)
1550High1526Low34.10KVolume1540Open1535Pre Close52.51MTurnover167952wk High0.31%Turnover Ratio17.63MShares118152wk Low126.2EPS TTM17.14BFloat Cap1839Historical High14.99P/E (Static)11.12MShs Float244Historical Low102.8EPS LYR1.56%Amplitude40.00Dividend TTM0.58P/B100Lot Size2.60%Div YieldTTM
Hirakawa Hewtech Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -8.99%29.33B | -7.32%6.98B | -6.92%8.09B | -14.50%7.11B | -7.02%7.15B | 15.90%32.22B | 18.04%7.53B | 16.99%8.69B | 15.40%8.32B | 13.22%7.69B |
| Cost of revenue | -6.56%22.8B | -3.45%5.37B | -0.39%6.35B | -14.04%5.57B | -7.93%5.5B | 11.90%24.4B | 8.61%5.56B | 9.91%6.38B | 14.85%6.48B | 14.17%5.98B |
| Gross profit | -16.58%6.53B | -18.31%1.61B | -24.89%1.74B | -16.08%1.55B | -3.92%1.64B | 30.40%7.83B | 56.53%1.97B | 42.33%2.31B | 17.26%1.84B | 10.10%1.71B |
| Operating expense | 2.92%4.86B | 1.69%1.26B | -1.83%1.18B | 7.11%1.25B | 5.05%1.17B | 16.77%4.72B | 21.29%1.24B | 20.20%1.2B | 16.45%1.17B | 9.14%1.11B |
| Staff costs | 4.07%2.12B | ---- | ---- | ---- | ---- | 15.40%2.04B | ---- | ---- | ---- | ---- |
| Research and development costs | -27.93%160M | ---- | ---- | ---- | ---- | 51.02%222M | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 13.62%267M | ---- | ---- | ---- | ---- | -2.49%235M | ---- | ---- | ---- | ---- |
| -Depreciation | 13.62%267M | ---- | ---- | ---- | ---- | -2.49%235M | ---- | ---- | ---- | ---- |
| Other operating expenses | 3.82%2.31B | ---- | ---- | ---- | ---- | 17.83%2.23B | ---- | ---- | ---- | ---- |
| Operating profit | -46.23%1.67B | -52.62%343M | -49.91%555M | -56.32%294M | -20.47%478M | 58.55%3.11B | 212.07%724M | 77.85%1.11B | 18.69%673M | 11.92%601M |
| Net non-operating interest income (expenses) | 460.00%140M | 136.36%26M | 312.50%66M | 2,600.00%25M | 2,400.00%23M | 177.78%25M | 450.00%11M | 300.00%16M | -120.00%-1M | 50.00%-1M |
| Non-operating interest income | 248.08%181M | 131.25%37M | 220.00%80M | 371.43%33M | 675.00%31M | 136.36%52M | 433.33%16M | 212.50%25M | -12.50%7M | 33.33%4M |
| Non-operating interest expense | 51.85%41M | 120.00%11M | 55.56%14M | 0.00%8M | 60.00%8M | 107.69%27M | 400.00%5M | 125.00%9M | 166.67%8M | 0.00%5M |
| Net investment income | 86.24%203M | -8.62%53M | 51.47%-99M | -140.15%-53M | 145.53%302M | 113.73%109M | -31.76%58M | -1,233.33%-204M | 1,300.00%132M | 400.00%123M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 307.14%29M | 0 | 566.67%20M | -14M | -17M | 3M | ||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -182.78%-452M | -5,833.33%-178M | -3,685.71%-265M | 0.00%-4M | -100.89%-5M | 54,700.00%546M | -200.00%-3M | -275.00%-7M | -500.00%-4M | 11,300.00%560M |
| Less:Other special charges | 182.33%452M | 5,833.33%178M | 3,685.71%265M | 300.00%4M | 100.89%5M | -2,789.47%-549M | --3M | --7M | 200.00%1M | -11,300.00%-560M |
| Less:Write off | --0 | --0 | --0 | ---- | ---- | -85.00%3M | --0 | --0 | ---- | ---- |
| Other non-operating income (expenses) | -33.08%89M | -42.65%39M | -80.95%4M | -5.00%19M | 12.50%27M | 209.30%133M | 142.86%68M | 2,000.00%21M | 81.82%20M | 700.00%24M |
| Income before tax | -57.09%1.67B | -66.91%277M | -69.94%282M | -64.59%290M | -36.88%825M | 89.46%3.9B | 141.91%837M | 44.09%938M | 43.18%819M | 166.73%1.31B |
| Income tax | -75.21%234M | -507.32%-334M | -21.97%135M | -40.06%187M | -34.75%246M | 69.78%944M | 18.84%82M | -0.57%173M | 90.24%312M | 153.02%377M |
| Net income | -51.34%1.44B | -19.18%611M | -80.78%147M | -79.84%102M | -37.74%579M | 96.74%2.96B | 172.92%756M | 60.04%765M | 24.32%506M | 172.73%930M |
| Net income continuous operations | -51.30%1.44B | -19.07%611M | -80.78%147M | -79.68%103M | -37.74%579M | 96.74%2.96B | 172.56%755M | 60.38%765M | 24.26%507M | 172.73%930M |
| Noncontrolling interests | -300.00%-4M | -400.00%-5M | 5M | -6M | 2M | -1M | -1M | 0 | 0 | 0 |
| Net income attributable to the company | -51.13%1.44B | -18.57%614M | -80.00%153M | -81.03%96M | -37.53%581M | 96.61%2.96B | 172.20%754M | 59.71%765M | 22.82%506M | 177.61%930M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -51.13%1.44B | -18.57%614M | -80.00%153M | -81.03%96M | -37.53%581M | 96.61%2.96B | 172.20%754M | 59.71%765M | 22.82%506M | 177.61%930M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -51.14%102.8 | -18.64%43.69 | -79.96%10.91 | -81.08%6.81 | -37.53%41.39 | 96.64%210.4 | 172.73%53.7 | 59.60%54.44 | 22.91%36 | 177.12%66.26 |
| Diluted earnings per share | -51.14%102.8 | -18.60%43.69 | -79.99%10.8918 | -81.08%6.81 | -37.53%41.39 | 96.64%210.4 | 172.60%53.6757 | 59.65%54.44 | 22.91%36 | 177.12%66.26 |
| Dividend per share | 0.00%36 | -18.18%18 | 0 | 28.57%18 | 0 | 33.33%36 | 62.96%22 | 0 | 3.70%14 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |